Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Vaxcyte.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $- | $- | $- | $- | $- | $- | $- | $- |
| Cost of Revenue | $- | $75.00M | $9.20M | $1.80M | $1.41M | $1.23M | $1.04M | $- |
| Gross Profit | $- | $-75.00M | $-9.20M | $-1.80M | $-1.41M | $-1.23M | $-1.04M | $- |
| Gross Profit Ratio | 0.00% | - | - | - | - | - | - | 0.00% |
| Research and Development Expenses | $476.64M | $332.34M | $169.45M | $78.41M | $73.56M | $45.61M | $30.14M | $12.79M |
| General and Administrative Expenses | $92.90M | $60.70M | $39.81M | $25.26M | $16.02M | $8.55M | $5.39M | $5.05M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $92.90M | $60.70M | $39.81M | $25.26M | $16.02M | $8.55M | $5.39M | $5.05M |
| Other Expenses | $- | $- | $-1.93M | $-1.58M | $-2.48M | $-237.00K | $5.18M | $- |
| Operating Expenses | $569.55M | $468.04M | $207.33M | $102.08M | $87.10M | $53.92M | $35.53M | $17.40M |
| Cost and Expenses | $- | $468.04M | $207.33M | $102.08M | $87.10M | $53.92M | $35.53M | $17.40M |
| Interest Income | $109.99M | $62.91M | $8.36M | $344.00K | $244.00K | $632.00K | $903.00K | $164.00K |
| Interest Expense | $- | $- | $2.00K | $7.00K | $7.00K | $40.00K | $75.00K | $- |
| Depreciation and Amortization | $- | $3.16M | $9.20M | $1.80M | $1.41M | $1.23M | $1.04M | $625.00K |
| EBITDA | $-569.55M | $-464.88M | $-214.29M | $-98.28M | $-87.81M | $-49.00M | $-28.37M | $-17.21M |
| EBITDA Ratio | - | - | - | - | - | - | - | - |
| Operating Income | $-569.55M | $-468.04M | $-232.26M | $-103.67M | $-89.58M | $-54.15M | $-35.53M | $-17.83M |
| Operating Income Ratio | - | - | - | - | - | - | - | - |
| Total Other Income Expenses Net | $105.62M | $65.78M | $8.77M | $3.59M | $364.00K | $3.88M | $6.05M | $595.00K |
| Income Before Tax | $-463.93M | $-402.27M | $-223.49M | $-100.08M | $-89.22M | $-50.27M | $-29.48M | $-17.24M |
| Income Before Tax Ratio | - | - | - | - | - | - | - | - |
| Income Tax Expense | $- | $- | $16.16M | $7.00K | $-1.40M | $3.23M | $6.12M | $- |
| Net Income | $-463.93M | $-402.27M | $-239.64M | $-100.08M | $-87.82M | $-53.50M | $-29.48M | $-17.24M |
| Net Income Ratio | - | - | - | - | - | - | - | - |
| EPS | $-3.80 | $-4.14 | $-3.69 | $-1.93 | $-2.97 | $-14.10 | $-8.12 | $-4.84 |
| EPS Diluted | $-3.80 | $-4.14 | $-3.69 | $-1.93 | $-2.97 | $-14.10 | $-8.12 | $-4.83 |
| Weighted Average Shares Outstanding | 122.00M | 97.16M | 64.88M | 51.92M | 29.55M | 3.79M | 3.63M | 3.56M |
| Weighted Average Shares Outstanding Diluted | 122.00M | 97.16M | 64.88M | 51.92M | 29.55M | 3.80M | 3.63M | 3.57M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $387.88M | $397.45M | $834.66M | $68.98M | $386.20M | $58.98M | $66.09M | $36.14M |
| Short Term Investments | $1.36B | $682.78M | $96.72M | $176.99M | $- | $- | $- | $- |
| Cash and Short Term Investments | $1.75B | $1.08B | $931.38M | $245.97M | $386.20M | $58.98M | $66.09M | $36.14M |
| Net Receivables | $- | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $-1.00M | $-1.20M | $-300.00K | $-200.00K | $- | $- |
| Other Current Assets | $40.78M | $15.73M | $5.31M | $9.18M | $2.50M | $2.75M | $578.00K | $209.00K |
| Total Current Assets | $1.79B | $1.10B | $942.55M | $256.35M | $389.00M | $61.72M | $66.67M | $36.35M |
| Property Plant Equipment Net | $270.15M | $110.62M | $31.65M | $35.91M | $3.27M | $3.39M | $3.41M | $2.97M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $1.39B | $162.68M | $26.55M | $27.12M | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $65.68M | $38.66M | $5.43M | $4.96M | $550.00K | $584.00K | $723.00K | $311.00K |
| Total Non-Current Assets | $1.72B | $311.96M | $63.62M | $67.99M | $3.82M | $3.98M | $4.13M | $3.28M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.70M | $70.80M | $39.63M |
| Account Payables | $48.45M | $14.59M | $9.79M | $6.76M | $29.79M | $3.38M | $2.83M | $1.81M |
| Short Term Debt | $5.89M | $7.11M | $11.82M | $10.55M | $- | $161.00K | $297.00K | $283.00K |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $-297.00K | $- |
| Other Current Liabilities | $85.84M | $123.64M | $18.91M | $11.41M | $17.08M | $7.51M | $3.59M | $2.17M |
| Total Current Liabilities | $140.18M | $145.34M | $40.52M | $28.72M | $46.86M | $11.05M | $6.71M | $4.26M |
| Long Term Debt | $65.22M | $22.11M | $12.03M | $11.51M | $- | $- | $161.00K | $4.22M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $100.00K | $- | $9.00K | $96.00K | $122.00K | $161.02M | $121.66M | $212.00K |
| Total Non-Current Liabilities | $65.32M | $22.11M | $12.04M | $11.60M | $122.00K | $161.02M | $121.82M | $4.43M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $205.50M | $167.45M | $52.56M | $40.32M | $46.98M | $172.07M | $128.53M | $8.69M |
| Preferred Stock | $- | $- | $- | $324.34M | $392.83M | $160.31M | $117.81M | $60.07M |
| Common Stock | $128.00K | $98.00K | $82.00K | $56.00K | $54.00K | $7.00K | $6.00K | $6.00K |
| Retained Earnings | $-1.39B | $-924.39M | $-522.13M | $-298.64M | $-198.56M | $-109.35M | $-59.07M | $-29.59M |
| Accumulated Other Comprehensive Income Loss | $-3.87M | $179.00K | $-361.00K | $-241.00K | $-392.83M | $-160.31M | $-1.75M | $- |
| Other Total Stockholders Equity | $4.70B | $2.16B | $1.48B | $582.84M | $151.53M | $323.59M | $3.09M | $452.00K |
| Total Stockholders Equity | $3.31B | $1.24B | $953.61M | $284.02M | $345.84M | $-106.37M | $-57.73M | $30.94M |
| Total Equity | $3.31B | $1.24B | $953.61M | $284.02M | $345.84M | $-106.37M | $-57.73M | $30.94M |
| Total Liabilities and Stockholders Equity | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.70M | $70.80M | $39.63M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.70M | $70.80M | $39.63M |
| Total Investments | $2.75B | $845.45M | $123.27M | $204.10M | $- | $- | $- | $- |
| Total Debt | $71.11M | $29.22M | $17.94M | $16.78M | $- | $161.00K | $458.00K | $4.22M |
| Net Debt | $-316.77M | $-368.23M | $-816.72M | $-52.20M | $-386.20M | $-58.81M | $-65.63M | $-31.92M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-463.93M | $-402.27M | $-223.49M | $-100.08M | $-89.22M | $-50.27M | $-29.48M | $-17.24K |
| Depreciation and Amortization | $15.85M | $10.17M | $9.20M | $3.46M | $1.41M | $1.23M | $1.04M | $625 |
| Deferred Income Tax | $- | $- | $- | $- | $301.00K | $1.00K | $51.00K | $- |
| Stock Based Compensation | $84.82M | $48.76M | $23.65M | $10.73M | $5.43M | $1.19M | $749.00K | $390 |
| Change in Working Capital | $-54.90M | $81.32M | $12.74M | $-37.01M | $35.27M | $3.91M | $1.90M | $1.00K |
| Accounts Receivables | $- | $- | $- | $- | $- | $868.00K | $1.27M | $- |
| Inventory | $- | $- | $- | $- | $- | $2.87M | $-1.19M | $- |
| Accounts Payables | $34.58M | $11.22M | $2.90M | $-12.47M | $26.10M | $868.00K | $1.27M | $- |
| Other Working Capital | $-89.48M | $70.09M | $9.84M | $-24.54M | $9.17M | $-698.00K | $550.00K | $1.00K |
| Other Non Cash Items | $-34.47M | $-34.77M | $7.30M | $1.50M | $179.00K | $-3.20M | $-4.71M | $260 |
| Net Cash Provided by Operating Activities | $-452.63M | $-296.79M | $-170.60M | $-121.39M | $-46.63M | $-47.15M | $-30.47M | $-14.96K |
| Investments in Property Plant and Equipment | $-22.43M | $-67.88M | $-5.85M | $-6.55M | $-1.16M | $-1.20M | $-1.77M | $-1.22K |
| Acquisitions Net | $- | $- | $7.00K | $26.00K | $50.00K | $- | $1.00K | $- |
| Purchases of Investments | $-3.09B | $-1.33B | $-102.75M | $-336.34M | $- | $- | $- | $- |
| Sales Maturities of Investments | $1.20B | $624.46M | $183.17M | $130.56M | $- | $- | $- | $- |
| Other Investing Activities | $-96.73M | $- | $80.43K | $-205.75K | $50 | $- | $1.00K | $106 |
| Net Cash Used for Investing Activities | $-2.01B | $-773.31M | $74.58M | $-212.31M | $-1.10M | $-1.20M | $-1.77M | $-1.12K |
| Debt Repayment | $- | $- | $- | $- | $-61.00K | $-278.00K | $-283.00K | $-188.00K |
| Common Stock Issued | $2.44B | $636.04M | $856.48M | $13.90M | $264.01M | $42.94M | $62.47M | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $12.85M | $3.77M | $5.07M | $3.90M | $110.92M | $41.84M | $62.47M | $231.86K |
| Net Cash Used Provided by Financing Activities | $2.45B | $639.81M | $861.55M | $17.80M | $374.87M | $41.57M | $62.19M | $43.86K |
| Effect of Forex Changes on Cash | $426.00K | $-6.69M | $137.00K | $-439.00K | $87.00K | $-341.00K | $- | $- |
| Net Change in Cash | $-9.36M | $-436.97M | $765.67M | $-316.34M | $327.22M | $-7.11M | $29.95M | $27.78K |
| Cash at End of Period | $389.19M | $398.55M | $835.53M | $69.86M | $386.20M | $58.98M | $66.09M | $36.14K |
| Cash at Beginning of Period | $398.55M | $835.53M | $69.86M | $386.20M | $58.98M | $66.09M | $36.14M | $8.36K |
| Operating Cash Flow | $-452.63M | $-296.79M | $-170.60M | $-121.39M | $-46.63M | $-47.15M | $-30.47M | $-14.96K |
| Capital Expenditure | $-22.43M | $-67.88M | $-5.85M | $-6.55M | $-1.16M | $-1.20M | $-1.77M | $-1.22K |
| Free Cash Flow | $-475.05M | $-364.67M | $-176.44M | $-127.95M | $-47.78M | $-48.34M | $-32.24M | $-16.18K |